Abstract

To investigate feasible treatment planning parameters, we aimed to evaluate the dosimetric and radiobiological impact of the dose calculation algorithm and grid size in the volumetric modulated arc therapy (VMAT) plan for prostate cancer. Twenty patients were selected, and the treatment plans were initially generated with anisotropic analytical algorithm (AAA) and recalculated with Acuros XB (AXB) algorithm. Various dose grids were used for AXB (1, 2, and 3 mm) and AAA (1, 3, and 5 mm) plan. Dosimetric parameters such as homogeneity index (HI) and conformity index (CI), and radiobiological parameters such as tumor control probability (TCP) and normal tissue complication probability (NTCP) were calculated. Significant differences were observed in the planning target volume (PTV) coverage between both algorithms, and the V95%, HI, and CI of AAA were significantly affected by grid (p < 0.01). On 1 mm grid, the mean rectal dose difference between both algorithms was 2.87% of the prescription dose (p < 0.01), which was the highest among the critical organs. The TCP and NTCP of the AAA were higher than those of AXB (p < 0.01). Compared to AXB with 1 mm grid, the 2 mm grid showed comparable dose calculation accuracy with short calculation time. This study found that the PTV and rectum show significant differences according to dose calculation algorithm and grid. Considering the dose calculation performance for heterogeneous area, we recommend AXB with 2 mm grid for improving treatment efficiency of prostate VMAT.

Highlights

  • Clinical use of volumetric-modulated arc therapy (VMAT) [1] has grown extremely since its debut in 2008

  • We investigate the dosimetric and radiological impact on prostate VMAT plans with endorectal balloon (ERB) from the dose calculation algorithms with different grid sizes

  • By using the ERB, an air cavity is usually generated in the rectum structure, which may cause a region of overlap between the planning target volume (PTV) and air cavity

Read more

Summary

Introduction

Clinical use of volumetric-modulated arc therapy (VMAT) [1] has grown extremely since its debut in 2008. The application of VMAT for prostate cancer has been well-demonstrated for both plan quality and efficiency [2, 3]. Impact of dose calculation grid and algorithms on prostate VMAT no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call